Consumer telehealth · Physician-led obesity care
Form Health
Form Health is a virtual obesity and cardiometabolic clinic where ABOM-certified physicians and registered dietitians deliver longitudinal care, with medication when appropriate. It is not a compounding-only refill marketplace.
Strong fit
- Employers and patients who want ABOM-certified physicians plus registered dietitians for longitudinal obesity care, not only a GLP-1 refill portal
- Benefits teams comparing clinical obesity programs that stay in-network with major plans
- Buyers who treat obesity as chronic disease management rather than a short compounded-semaglutide campaign
Weak fit
- Shoppers who only want the cheapest compounded GLP-1 with minimal clinician contact
- Health systems building their own endocrinology obesity clinic and refusing an external virtual specialty partner
- Buyers requiring on-prem enterprise software rather than a virtual care program
Bottom line
Form Health earns a Recommend near the top of our weight-care board for buyers who want physician-led obesity and cardiometabolic care rather than a thin cash-pay GLP-1 funnel. Founder-CEO Evan Richardson and CMO Dr. Florencia Halperin position the model around ABOM physicians, CSOWM dietitians, and FDA-approved medication when appropriate, with employer and health-plan channels alongside direct patients. Third-party revenue estimates span a wide mid-market band (roughly low tens to under $100M) with a few hundred employees after Series B funding, under the hard cap. Ease of joining is stronger for insured and employer-sponsored members than for bargain compounded-only shoppers. Score sits above Found on clinical specialty depth and above Calibrate when one-to-one physician plus dietitian continuity is the buying question.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Form Health is a Boston virtual obesity and cardiometabolic clinic founded in 2019 by CEO Evan Richardson. Patients work one-to-one with ABOM-certified physicians and registered dietitians rather than progressing through a purely asynchronous refill chatbot.
It is clinical obesity telehealth, not a hospital EMR and not a compounding-first DTC brand. Compare Found when the buyer wants a mainstream weight-care consumer brand, Calibrate when the purchase is an employer GLP-1 cost-management program, and Henry Meds or GobyMeds when the only job is low-cost compounded incretin access.
Score reflects stronger clinical model depth than cash-pay compounders, with pricing clarity limited by insurance variability.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Form Health | 7.5 | 7.3 |
| Found | 7.4 | 7.2 |
| Calibrate | 7.3 | 7.1 |
| Eden | 7.3 | 7.2 |
| Fridays | 7.1 | 7.0 |
| Mochi Health | 7.0 | 6.6 |
| Nu Image Medical | 6.8 | 6.5 |
| Sesame | 6.8 | 6.7 |
| Henry Meds | 6.7 | 6.3 |
| GobyMeds | 6.6 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | Virtual specialty obesity care billed through insurance, employer benefits, and self-pay pathways; medication cost is separate when prescribed. |
| What usually drives cost | Coverage pathway (in-network vs employer vs self-pay), visit frequency, dietitian intensity, and whether branded GLP-1s are covered. |
| What to ask in diligence | Member responsibility after insurance or employer subsidy, plus expected medication out-of-pocket for your formulary. |
| Published pricing | Program pricing depends on insurance and employer contracts; confirm current member estimates on formhealth.co. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Form Health to function | |
| Benefits or insurance pathway identified | Members stall without coverage clarity. |
| Obesity clinical eligibility criteria agreed | Wrong referrals waste clinician time. |
| Medication formulary expectations set | Surprise GLP-1 denials drive churn. |
| Dietitian and physician visit cadence defined | Continuity fails if cadence is vague. |
| Member communication owner named | No owner means missed onboarding. |
| What will maximize your value | |
| Enroll a defined cohort in 30 days | Partial launches hide signal. |
| Track weight and A1C outcomes at 90 days | Prove clinical value. |
| Align PBM prior-auth with clinical notes | Medication delays kill adherence. |
| Deal-breakers | |
| Cash compounded-only mandate with no clinician visits | |
| On-prem software RFP only | |
| No benefits sponsor | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Benefits contracting | 2-8 weeks |
| 2 | Member launch | 2-4 weeks |
| 3 | Outcomes review | ongoing |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.